# æ–‡ç»ç­†è¨˜è³‡æ–™å¤¾

é€™å€‹è³‡æ–™å¤¾ç”¨ä¾†å­˜æ”¾ domain knowledge ç ”ç©¶éç¨‹ä¸­çš„æ–‡ç»ç­†è¨˜å’Œç ”ç©¶è³‡æ–™ã€‚

## ğŸ“‚ è³‡æ–™å¤¾çµæ§‹

### æŒ‰ç ”ç©¶æ¶æ§‹åˆ†é¡ï¼š
- `01_clinical_standards/` - åŸºç¤å®šç¾© & è‡¨åºŠè¨ºæ–·æ¨™æº–
- `02_epidemiology/` - ä¸‰é«˜çš„æµè¡Œç—…å­¸èƒŒæ™¯
- `03_clinical_associations/` - è‡¨åºŠèˆ‡ç”Ÿç†é—œè¯
- `04_data_sources/` - è³‡æ–™ä¾†æºèˆ‡å¸¸è¦‹æŒ‡æ¨™
- `05_research_methods/` - ç ”ç©¶æ–¹æ³• & æ‡‰ç”¨å ´æ™¯
- `06_controversies/` - çˆ­è­°èˆ‡ç ”ç©¶ç©ºç™½

### å…¶ä»–ï¼š
- `key_papers/` - é‡è¦è«–æ–‡å…¨æ–‡æˆ–æ‘˜è¦
- `datasets_review/` - ç›¸é—œè³‡æ–™é›†æ¯”è¼ƒåˆ†æ
- `meeting_materials/` - PPT æº–å‚™ææ–™

## ğŸ“ ç­†è¨˜æ ¼å¼å»ºè­°

æ¯ç¯‡æ–‡ç»ç­†è¨˜åŒ…å«ï¼š
1. **åŸºæœ¬è³‡è¨Š**ï¼šä½œè€…ã€æœŸåˆŠã€å¹´ä»½ã€DOI
2. **ç ”ç©¶ç›®çš„**ï¼šè§£æ±ºä»€éº¼å•é¡Œ
3. **æ–¹æ³•**ï¼šè³‡æ–™ã€æ¨¡å‹ã€è©•ä¼°æŒ‡æ¨™
4. **çµæœ**ï¼šä¸»è¦ç™¼ç¾
5. **å•Ÿç™¼**ï¼šå°æˆ‘å€‘ç ”ç©¶çš„æ„ç¾©
6. **å¼•ç”¨åƒ¹å€¼**ï¼šå¯ç”¨æ–¼è«–æ–‡å“ªå€‹éƒ¨åˆ†

## ğŸ” æ–‡ç»æœå°‹ç­–ç•¥

**è³‡æ–™åº«**ï¼š
- PubMed (é†«å­¸æ–‡ç»)
- Google Scholar (è·¨é ˜åŸŸ)
- IEEE Xplore (å·¥ç¨‹æŠ€è¡“)

**é—œéµå­—çµ„åˆ**ï¼š
- interpretable machine learning + hypertension/diabetes/dyslipidemia
- cardiovascular risk prediction + explainable AI
- three highs + machine learning (ä¸­æ–‡ï¼šä¸‰é«˜)
- metabolic syndrome + risk assessment